BioSpectrum Webinar explores strategies for 'Make in India' in LifeSciences- post lockdown!
May 22, 2020 | Friday | Views
COVID-19 is playing a catalytic role by enabling India's best innovative minds to develop solutions towards easing the healthcare community pressure and help save lives
COVID-19 has offered a unique opportunity for India to re-charge its "Make in India" mantra. For example, the current dependency of Indian pharma companies on Chinese APIs has prompted the government to review the country's situation in the API sector.
Likewise, COVID-19 is playing a catalytic role by enabling India's best innovative minds to develop solutions towards easing the healthcare community pressure and help save lives. Perhaps it is time for India to emerge as a leader in the life sciences sector.
But the bigger Question is how to make it happen. And to get answers to this, we have the experts right here with us.
Dr Satya Prakash Dash, Founding & Former Head of Strategy, Partnerships & Entrepreneurship Development, Biotechnology Industry Research Assistance Council (BIRAC)
Praveen Gupta, Managing Director, Premas Life Sciences, Gurugram
Dr Prabuddha Kundu, Co-founder & Managing Director, Premas Biotech, Gurugram
Dr Rakesh Mishra, Director, Centre for Cellular & Molecular Biology (CCMB), Hyderabad
Dr. Renu John, Professor & Head of the Department, Biomedical Engineering, Indian Institute of Technology (IIT), Hyderabad
Watch our latest webinar video to get all the answers